C-type like lectin molecule 1 (CLL-1)-specific chimeric antigen receptor (CAR) T cell therapy for the treatment of acute myeloid leukemia (AML)

被引：0
|
作者：
Schanda, N. [1 ]
Sedloev, D. [1 ]
Schmitt, A. [1 ]
Mueller-Tidow, C. [1 ]
Schmitt, M. [1 ]
Sauer, T. [1 ]
机构：
[1] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V544
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [1] Optimizing C-Type Lectin-like Molecule 1 (CLL-1) Directed CAR T Cell Therapy of Acute Myeloid Leukemia
    Atilla, Pinar Ataca
    Atilla, Erden
    Tashiro, Haruko
    Srinivasan, Madhuwanti
    Silva, Diogo Gomes
    Mamonkin, Maksim
    Brenner, Malcolm K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [2] Primary natural killer (NK) cells expressing a C-type like lectin molecule 1 (CLL-1)-specific Chimeric Antigen Receptor (CAR) exhibit potent antigen-specific activity against acute myeloid leukemia (AML)
    Sedloev, D.
    Schanda, N.
    Schmitt, A.
    Mueller-Tidow, C.
    Schmitt, M.
    Sauer, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 89 - 89
  • [3] Chimeric Antigen Receptor T Cells Specific for CLL-1 for Treatment of Actue Myeloid Leukemia
    De Togni, Elisa
    Kim, Miriam Y.
    Cooper, Matt L.
    Ritchey, Julie
    O'Neal, Julie
    Niswonger, Jessica
    DiPersio, John F.
    BLOOD, 2018, 132
  • [4] Development of a 3-Day DashCAR-T Cell Therapy Against C-Type Lectin-Like Molecule 1 (CLL-1) for Acute Myeloid Leukemia
    Kuan, Chien-Tsun
    Huang, Kao-Jean
    Chang, Alex
    Yeh, Hom-Ming
    Yang, Shun-Jen
    MOLECULAR THERAPY, 2023, 31 (04) : 616 - 617
  • [5] Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1
    Tashiro, Haruko
    Sauer, Tim
    Shum, Thomas
    Parikh, Kathan
    Mamonkin, Maksim
    Omer, Bilal
    Rouce, Rayne H.
    Lulla, Premal
    Rooney, Cliona M.
    Gottschalk, Stephen
    Brenner, Malcolm K.
    MOLECULAR THERAPY, 2017, 25 (09) : 2202 - 2213
  • [6] Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
    Hofmann, Susanne
    Schubert, Maria-Luisa
    Wang, Lei
    He, Bailin
    Neuber, Brigitte
    Dreger, Peter
    Mueller-Tidow, Carsten
    Schmitt, Michael
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [7] CLL-1 specific chimeric antigen receptor T cells (CART) as a novel AML therapy
    Freitas, Antonio
    Gautron, Anne-Sophie
    Sugita, Mayumi
    Goswami, Srinjoy
    Galetto, Roman
    Garton, Andrew
    Smith, Julianne
    Gouble, Agnes
    Becker, Michael W.
    Roboz, Gail J.
    Guzman, Monica L.
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia
    Laborda, Eduardo
    Mazagova, Magdalena
    Shao, Sida
    Wang, Xinxin
    Quirino, Herlinda
    Woods, Ashley K.
    Hampton, Eric N.
    Rodgers, David T.
    Kim, Chan Hyuk
    Schultz, Peter G.
    Young, Travis S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [9] Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)
    Acharya, Utkarsh H.
    Walter, Roland B.
    CANCERS, 2020, 12 (12) : 1 - 28
  • [10] Expression of C-Type Lectin-Like Molecule-1 (CLL-1) on Stem Cells Might Discriminate De NovoAcute Myeloid Leukemia from Acute Myeloid Leukemia Originating from Myelodysplastic Syndromes.
    Westers, Theresia M.
    Terwijn, Monique
    Alhan, Canan
    van der Veeken, Yvonne F. C. M.
    Cali, Claudia
    Kelder, Angele
    van Rhenen, Anna
    Schuurhuis, Gerrit Jan
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    BLOOD, 2008, 112 (11) : 933 - 933
12345